Since the promoter of E-Cadherin is frequently found to be hypermethylated in prostate tumors and PCa cell lines and can be reversed by demethylation, it is likely that hypermethylation accounts for the reduced expression [31]. This evidence concerns the gene CDH1 and posterior cortical atrophy.